糖尿病指南

订阅

MedSci主页 / 所有栏目 / 糖尿病指南

德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月

2020-10-05 Ophthalmologe . 2020 Oct 8. doi: 10.1007/s00347-020-01244-w

糖尿病性黄斑水肿

德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月

中文标题：

德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月

英文标题：

Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019

发布机构：

发布日期：

2020-10-05

简要介绍：

德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月

相关资料下载：
[AttachmentFileName(sort=1, fileName=66.pdf)] GetToolGuiderByIdResponse(projectId=1, id=a26721c001992174, title=德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月, enTitle=Statement of the German Ophthalmological Society, the German Retina Society, and the Professional Association of Ophthalmologists in Germany on treatment of diabetic macular edema : Dated August 2019, guiderFrom=Ophthalmologe . 2020 Oct 8. doi: 10.1007/s00347-020-01244-w, authorId=0, author=, summary=德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月, cover=, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Mon Oct 05 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<p>德国眼科学会，德国视网膜学会和德国眼科医师专业协会关于糖尿病性黄斑水肿治疗的声明：2019年8月</p>, tagList=[TagDto(tagId=32673, tagName=糖尿病性黄斑水肿)], categoryList=[CategoryDto(categoryId=8, categoryName=糖尿病, tenant=100), CategoryDto(categoryId=32, categoryName=眼科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=0, guiderKeyword=, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=1, guiderRegion=2, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3511, appHits=185, showAppHits=0, pcHits=392, showPcHits=3326, likes=0, shares=15, comments=14, approvalStatus=1, publishedTime=Mon Oct 19 18:16:18 CST 2020, publishedTimeString=2020-10-05, pcVisible=1, appVisible=1, editorId=4754896, editor=fbzhang, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=fbzhang, createdTime=Mon Oct 19 18:16:12 CST 2020, updatedBy=4754896, updatedName=fbzhang, updatedTime=Sat Jan 06 20:30:52 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=66.pdf)])
66.pdf
下载请点击：
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2099238, encodeId=68f520992381d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:47:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207361, encodeId=8955120e361d3, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a296582368, createdName=ms8000000978627069, createdTime=Wed Mar 30 22:21:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964591, encodeId=b22f96459100, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:51:39 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921015, encodeId=3e2992101568, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=mX6wCWTDGOn0icuL1ZIicuoQ&s=100&t=1571141045, createdBy=e9b95294931, createdName=小蓝波, createdTime=Fri Jan 29 13:27:48 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914255, encodeId=63e5914255c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9765443823, createdName=ms9000001761974769, createdTime=Thu Jan 07 00:10:14 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2022-11-08 朽木青渠

    学习学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2099238, encodeId=68f520992381d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:47:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207361, encodeId=8955120e361d3, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a296582368, createdName=ms8000000978627069, createdTime=Wed Mar 30 22:21:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964591, encodeId=b22f96459100, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:51:39 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921015, encodeId=3e2992101568, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=mX6wCWTDGOn0icuL1ZIicuoQ&s=100&t=1571141045, createdBy=e9b95294931, createdName=小蓝波, createdTime=Fri Jan 29 13:27:48 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914255, encodeId=63e5914255c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9765443823, createdName=ms9000001761974769, createdTime=Thu Jan 07 00:10:14 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2022-03-30 ms8000000978627069

    好东西

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2099238, encodeId=68f520992381d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:47:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207361, encodeId=8955120e361d3, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a296582368, createdName=ms8000000978627069, createdTime=Wed Mar 30 22:21:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964591, encodeId=b22f96459100, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:51:39 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921015, encodeId=3e2992101568, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=mX6wCWTDGOn0icuL1ZIicuoQ&s=100&t=1571141045, createdBy=e9b95294931, createdName=小蓝波, createdTime=Fri Jan 29 13:27:48 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914255, encodeId=63e5914255c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9765443823, createdName=ms9000001761974769, createdTime=Thu Jan 07 00:10:14 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-05-11 1486c135m42(暂无昵称)

    好好学习

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2099238, encodeId=68f520992381d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:47:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207361, encodeId=8955120e361d3, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a296582368, createdName=ms8000000978627069, createdTime=Wed Mar 30 22:21:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964591, encodeId=b22f96459100, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:51:39 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921015, encodeId=3e2992101568, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=mX6wCWTDGOn0icuL1ZIicuoQ&s=100&t=1571141045, createdBy=e9b95294931, createdName=小蓝波, createdTime=Fri Jan 29 13:27:48 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914255, encodeId=63e5914255c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9765443823, createdName=ms9000001761974769, createdTime=Thu Jan 07 00:10:14 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-01-29 小蓝波

    好好学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2099238, encodeId=68f520992381d, content=学习学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200912/39dc01e1c37446dda0bcd038f6af9623/734e2f02d0c7454db686257557ce8fef.jpg, createdBy=86945417602, createdName=朽木青渠, createdTime=Tue Nov 08 19:47:43 CST 2022, time=2022-11-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1207361, encodeId=8955120e361d3, content=好东西, beContent=null, objectType=guider, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a296582368, createdName=ms8000000978627069, createdTime=Wed Mar 30 22:21:35 CST 2022, time=2022-03-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=964591, encodeId=b22f96459100, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=f6d25293791, createdName=1486c135m42(暂无昵称), createdTime=Tue May 11 14:51:39 CST 2021, time=2021-05-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=921015, encodeId=3e2992101568, content=好好学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/g?b=oidb&k=mX6wCWTDGOn0icuL1ZIicuoQ&s=100&t=1571141045, createdBy=e9b95294931, createdName=小蓝波, createdTime=Fri Jan 29 13:27:48 CST 2021, time=2021-01-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=914255, encodeId=63e5914255c7, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=59, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a9765443823, createdName=ms9000001761974769, createdTime=Thu Jan 07 00:10:14 CST 2021, time=2021-01-07, status=1, ipAttribution=)]
    2021-01-07 ms9000001761974769

    学习

    0

相关指南

2015 NICE技术评估指南：阿柏西普治疗糖尿病性黄斑水肿（TA346）

暂未更新 · 2015-07-22